SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1.

Journal: Acta pharmaceutica Sinica. B •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Du L, Wang M, Liu X, et al. (2026). "SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.07.042